Physician profile
Anthony E Barnes
NPI 1063410173
$88,650.66
in general payments reported to CMS, 2019-2025
26 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,031 · 2020: $79.11 · 2021: $1,365 · 2022: $659 · 2023: $25K · 2024: $30K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $85K · Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $84,583.34 |
| Food and Beverage | $933.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $84,656.35 | 2022-2025 | Nanoknife, Nanoknife |
| E.R. Squibb & Sons, L.L.C. | $1,365.00 | 2021 | |
| Coloplast Corp | $1,152.90 | 2019-2024 | |
| Blue Earth Diagnostics | $195.20 | 2022-2024 | |
| Medtronic, INC. | $180.43 | 2022-2024 | Interstim |
| Rochester Medical Corporation | $128.63 | 2022 | |
| Endo Pharmaceuticals INC. | $106.48 | 2022-2024 | Xiaflex, Aveed |
| Axonics, INC. | $99.73 | 2023-2024 | Axonics |
| Sumitomo Pharma America, INC. | $96.32 | 2023-2025 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $95.66 | 2022-2023 | Myrisk |
| Astellas Pharma US INC | $69.74 | 2022-2024 | Xtandi |
| Endo USA, INC. | $67.30 | 2024-2025 | Xiaflex |
| Abbvie INC. | $62.41 | 2022-2024 | Lupron Depot |
| Astrazeneca Pharmaceuticals LP | $48.24 | 2022-2023 | Lynparza |
| Boston Scientific Corporation | $48.22 | 2022-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $40.98 | 2022-2023 | Erleada |
| Abc Home Medical Supply, INC. | $37.89 | 2022-2023 | |
| Procept Biorobotics Corporation | $28.18 | 2024 | Aquabeam System |
| Tolmar, INC. | $28.05 | 2024 | |
| Immunitybio, INC. | $25.26 | 2025 | |
| Glaxosmithkline, LLC. | $24.90 | 2019-2020 | |
| Accord Healthcare, INC. | $24.53 | 2024 | |
| Palette Life Sciences, INC. | $21.78 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.22 | 2025 | |
| Teleflex LLC | $16.19 | 2024 | Urolift |
| Myovant Sciences INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.